Milestone Pharmaceuticals Inc.（MIST）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · MIST · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$1.55M	$0.00M	$1.00M	$5.00M	$15.00M
Cost of Revenue	$0.11M	$0.00M	$0.00M	$0.00M	$0.00M
Gross Profit	$1.43M	$0.00M	$1.00M	$5.00M	$15.00M
Gross Margin %(computed)	92.63%	—	100.00%	100.00%	100.00%
Operating Expenses
R&D Expenses	$18.11M	$14.36M	$31.05M	$39.83M	$38.67M
G&A Expenses	$17.27M	$16.74M	$15.93M	$15.72M	$12.40M
Total Operating Expenses	$63.92M	$42.10M	$62.10M	$64.64M	$58.07M
Operating Income	($62.48M)	($42.10M)	($61.10M)	($59.64M)	($43.07M)
Operating Margin %(computed)	—	—	—	—	-287.15%
Interest Income	$2.92M	$4.16M	$3.97M	$1.25M	$0.22M
Interest Expense	$3.84M	($3.58M)	$2.55M	$0.00M	$0.00M
Income Before Tax	($63.40M)	($41.52M)	($59.69M)	($58.39M)	($42.85M)
Income Tax Expense	($0.34M)	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	($63.06M)	($41.52M)	($59.69M)	($58.39M)	($42.85M)
Net Margin %(computed)	—	—	—	—	-285.69%
Per Share & EBITDA
EPS (Basic)	$-0.75	$-0.67	$-1.39	$-1.35	$-1.02
Wtd Avg Shares	83.88M	62.21M	42.96M	42.45M	41.83M
EBITDA	($62.14M)	($37.83M)	($57.04M)	($58.30M)	($42.98M)
EBITDA Margin %(computed)	—	—	—	—	-286.53%